Owners, management and financials
CVR: 29178291
Secondary names: PHARMAORIGIN.COM ApS
Previous names: ApS KBUS 17 NR. 4503
DKK 0
Gross profit
Net result: DKK 100,000
Savara ApS (100%)
CVR · view owners
Danielle Marie Brown
CVR · view management
Active
Founded 14 November 2005
CVR · view overview
0 employees
CVR · 2008
Director role ended: David Lee Lowrance
CVR · 17/06/2026
View the full event history
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.
Selskabets formål er at udvikle lægemidler samt dermed beslægtede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | 100 t. | 1.5 mio. | 1.5 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | - | 94 t. | 1.4 mio. | 1.4 mio. | - | |
| 202301/01/2023 – 31/12/2023 | - | 87 t. | 1.3 mio. | 1.3 mio. | - | |
| 202201/01/2022 – 31/12/2022 | - | 47 t. | 1.2 mio. | 1.2 mio. | - | |
| 202101/01/2021 – 31/12/2021 | - | 40 t. | 1.2 mio. | 1.1 mio. | - | |
| 202001/01/2020 – 31/12/2020 | - | 13 t. | 1.1 mio. | 1.1 mio. | - | |
| 201901/01/2019 – 31/12/2019 | - | 18 t. | 1.1 mio. | 1.1 mio. | 0 | |
| 201801/01/2018 – 31/12/2018 | - | -23 t. | 1.1 mio. | 1.1 mio. | - | |
| 201701/01/2017 – 31/12/2017 | - | -4.3 mio. | 1.1 mio. | 1.1 mio. | - | |
| 201601/01/2016 – 31/12/2016 | - | -1.7 mio. | 5.4 mio. | 5.4 mio. | - | |
| 201501/01/2015 – 31/12/2015 | - | -135 t. | 7 mio. | 4.2 mio. | - | |
| 201401/01/2014 – 31/12/2014 | - | -558 t. | 5.6 mio. | 4.3 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 0 | -938 t. | 5.3 mio. | -132 t. | - | |
| 201201/01/2012 – 31/12/2012 | - | -149 t. | 4.9 mio. | 806 t. | - |
Compared to 284 companies in Drift af sundhedsvæsen i øvrigt i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of PHARMAORIGIN ApS is 29178291.
PHARMAORIGIN ApS is owned by Savara ApS.
The management of PHARMAORIGIN ApS consists of Danielle Marie Brown.
In 2025, PHARMAORIGIN ApS reported a gross profit of DKK 0.
PHARMAORIGIN ApS had 0 employees in 2008 according to the Danish CVR register.
PHARMAORIGIN ApS was founded on 14 November 2005.
Claim this page to add your logo and social links. Free to get started.
PHARMAORIGIN ApS has published its annual report for 2025. Gross profit came to DKK 0, and the net result was DKK 100,000.
As of June 17, 2026, Danielle Marie Brown is registered as director of PHARMAORIGIN ApS.
As of June 17, 2026, David Lee Lowrance has stepped down as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 94,000.
PHARMAORIGIN ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 87,000.
PHARMAORIGIN ApS has published its annual report for 2022. The net result was DKK 47,000.
PHARMAORIGIN ApS has published its annual report for 2021. The net result was DKK 40,000.
PHARMAORIGIN ApS has published its annual report for 2020. The net result was DKK 13,000.
As of September 11, 2020, Robert Norman Neville has stepped down as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2019. The net result was DKK 18,000.
PHARMAORIGIN ApS has published its annual report for 2018. The net result was DKK -23,000.
PHARMAORIGIN ApS has published its annual report for 2017. The net result was DKK -4,332,000.
PHARMAORIGIN ApS has published its annual report for 2016. The net result was DKK -1,713,000.
As of June 1, 2017, David Lee Lowrance is registered as director of PHARMAORIGIN ApS.
As of July 15, 2016, Robert Norman Neville is registered as director of PHARMAORIGIN ApS.
As of July 15, 2016, Kim Arvid Nielsen has stepped down as adm. dir. of PHARMAORIGIN ApS.
As of July 15, 2016, Savara ApS is registered as an owner of PHARMAORIGIN ApS with an ownership share of 100%.
PHARMAORIGIN ApS has published its annual report for 2015. The net result was DKK -135,000.
As of January 22, 2016, Søren Bech Justesen has stepped down as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2014. The net result was DKK -558,000.
As of June 1, 2015, Søren Bech Justesen is registered as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK -937,714.
As of December 27, 2013, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of PHARMAORIGIN ApS.
As of December 27, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of PHARMAORIGIN ApS.
As of October 29, 2013, Kim Arvid Nielsen is registered as adm. dir. of PHARMAORIGIN ApS.
As of October 29, 2013, Henrik Lasse Lindblad has stepped down as adm. dir. of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2012. The net result was DKK -149,195.
As of June 21, 2012, Lars Heslet has left the board of directors of PHARMAORIGIN ApS.
As of June 21, 2012, Eric Jean Marie Leire has left the board of directors of PHARMAORIGIN ApS.
As of October 19, 2011, Henrik Lasse Lindblad is registered as adm. dir. of PHARMAORIGIN ApS.
As of October 19, 2011, Lars Heslet has stepped down as director of PHARMAORIGIN ApS.
As of August 31, 2011, Kaare Fiala has left the board of directors of PHARMAORIGIN ApS.
As of August 31, 2011, Kaare Fiala has stepped down as adm. dir. of PHARMAORIGIN ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMAORIGIN ApS.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of PHARMAORIGIN ApS.
As of April 12, 2011, Peter Høngård Andersen has left the board of directors of PHARMAORIGIN ApS.
As of April 12, 2011, Leif Helth Jensen has left the board of directors of PHARMAORIGIN ApS.
As of January 1, 2008, Peter Høngård Andersen has joined the board of directors of PHARMAORIGIN ApS.
As of November 30, 2007, A/S PSE NR. 4820 has been appointed auditor of PHARMAORIGIN ApS.
As of November 30, 2007, DKNF 387 ApS has stepped down as auditor of PHARMAORIGIN ApS.
As of November 29, 2007, Lars Heslet has joined the board of directors of PHARMAORIGIN ApS.
As of November 29, 2007, Leif Helth Jensen has joined the board of directors of PHARMAORIGIN ApS.
As of November 29, 2007, Eric Jean Marie Leire has joined the board of directors of PHARMAORIGIN ApS.
As of November 29, 2007, Kaare Fiala has joined the board of directors of PHARMAORIGIN ApS.
As of December 12, 2006, Tom Glæsner Larsen has stepped down as director of PHARMAORIGIN ApS.
As of October 1, 2006, Kaare Fiala is registered as adm. dir. of PHARMAORIGIN ApS.
As of December 2, 2005, Lars Heslet is registered as director of PHARMAORIGIN ApS.
As of November 23, 2005, DKNF 387 ApS has been appointed auditor of PHARMAORIGIN ApS.
As of November 23, 2005, JUT NR. 2180 A/S has stepped down as auditor of PHARMAORIGIN ApS.
As of November 23, 2005, Tom Glæsner Larsen is registered as director of PHARMAORIGIN ApS.
As of November 23, 2005, Peter Andreas Stakemann has stepped down as director of PHARMAORIGIN ApS.
On November 23, 2005, the company changed its name from ApS KBUS 17 NR. 4503 to PHARMAORIGIN ApS.
As of November 14, 2005, JUT NR. 2180 A/S has been appointed auditor of PHARMAORIGIN ApS.
As of November 14, 2005, Peter Andreas Stakemann is registered as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS was founded on November 14, 2005.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 32919022
CVR 38900137
CVR 45591743
CVR 45819736
CVR 45338282
